Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (501-510 of 7,109) with videos related to

Pageof 711
Sort By:
Cancer Science|July 27, 2018
HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancerMinghui Liu, Hongyi Zhang, Ying Li, et al.
Cancer Science|April 7, 2011
Hypoxia-induced β-catenin downregulation involves p53-dependent activation of Siah-1Dapeng Wang, Yongxing Wang, Tao Kong, et al.
Cancer Science|April 28, 2011
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer modelMin Wei, Li Zhu, Yafen Li, et al.
Cancer Science|January 31, 2006
Enhanced SMYD3 expression is essential for the growth of breast cancer cellsRyuji Hamamoto, Fabio Pittella Silva, Masataka Tsuge, et al.
Cancer Science|January 31, 2006
Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancerSatoshi Ishizone, Kazuyoshi Yamauchi, Shigeyuki Kawa, et al.
Cancer Science|January 31, 2006
Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignanciesHiroshi Iwata, Keitaro Matsuo, Shigeo Hara, et al.
Cancer Science|January 31, 2006
Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinibMitsuhiro Matsuo, Hiroaki Sakurai, Yoko Ueno, et al.
Cancer Science|April 24, 2010
Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significanceAmlan Ghosh, Susmita Ghosh, Guru Prasad Maiti, et al.
Cancer Science|April 20, 2010
DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomasKhaled Amara, Sonia Ziadi, Mohamed Hachana, et al.
Cancer Science|April 20, 2010
Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancerHyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Pageof 711

Showing results (501-510 of 7,109) with videos related to

Sort By:
Pageof 711
Cancer Science|July 27, 2018
HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancerMinghui Liu, Hongyi Zhang, Ying Li, et al.
Cancer Science|April 7, 2011
Hypoxia-induced β-catenin downregulation involves p53-dependent activation of Siah-1Dapeng Wang, Yongxing Wang, Tao Kong, et al.
Cancer Science|April 28, 2011
Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer modelMin Wei, Li Zhu, Yafen Li, et al.
Cancer Science|January 31, 2006
Enhanced SMYD3 expression is essential for the growth of breast cancer cellsRyuji Hamamoto, Fabio Pittella Silva, Masataka Tsuge, et al.
Cancer Science|January 31, 2006
Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancerSatoshi Ishizone, Kazuyoshi Yamauchi, Shigeyuki Kawa, et al.
Cancer Science|January 31, 2006
Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignanciesHiroshi Iwata, Keitaro Matsuo, Shigeo Hara, et al.
Cancer Science|January 31, 2006
Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinibMitsuhiro Matsuo, Hiroaki Sakurai, Yoko Ueno, et al.
Cancer Science|April 24, 2010
Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significanceAmlan Ghosh, Susmita Ghosh, Guru Prasad Maiti, et al.
Cancer Science|April 20, 2010
DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomasKhaled Amara, Sonia Ziadi, Mohamed Hachana, et al.
Cancer Science|April 20, 2010
Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancerHyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Pageof 711